Background: The eligibility of patients with Brugada syndrome (BrS) for implantation of a subcutaneous implantable cardioverter defibrillator (S-ICD) is not well known. This study aimed to clarify the eligibility of BrS patients for S-ICD using electrocardiography (ECG) at rest and during exercise testing. We also analyzed factors associated with ineligibility for S-ICD from standard 12-lead ECG at rest.
INTRODUCTION
Brugada syndrome (BrS) is a genetic disease responsible for 4-12% of cases of sudden cardiac death (SCD). 1 The syndrome is characterized by an electrocardiographic pattern of ST segment elevation with type 1 morphology in the right precordial leads V1 to V3. Most cardiac events occur in middle-aged men. 2, 3 Symptoms often arise at rest or during sleep, in a febrile state.
Lethal ventricular arrhythmias tend to occur during the recovery phase after exercise, in association with significant augmentation of ST elevation. 4 A subcutaneous implantable cardioverter-defibrillator (S-ICD) does not require placement of leads directly into the heart, so use of these devices could avoid the complications related to the use of transvenous ICD leads. Moreover, since the incidence of lead injury increases over time after transvenous ICD implantation, use of S-ICDs is expected to avoid troubles concerning cardiac leads, [5] [6] [7] especially in younger patients without organic heart disease, such as patients with BrS, who do not usually need ventricular pacing. 8 However, the eligibility of BrS patients for S-ICD use is not well known, and data from a large cohort of this specific patient population have not been reported. 9 The most common problem with S-ICD systems in the real world is administration of inappropriate shocks because of T-wave oversensing. 10 To avoid this problem, the manufacturer has developed a system to identify patients who are likely to be unsuitable for S-ICD, using supine and standing surface ECG screening templates. Moreover, ST-T morphology shows fluctuations, particularly in high-risk patients with BrS. 11 This suggests that ECG at rest should not be considered sufficient as S-ICD screening for patients with diurnal variations. Exercise is one of the most important factors for ST-T fluctuations, and exercise-induced ST-T changes thus need to be considered when making decisions regarding S-ICD implantation. In addition, because the specific ECG system templates proposed for determining S-ICD eligibility are uncommon and inconvenient for actual clinical practice, parameters derived from standard 12-lead ECG are expected to be used to eliminate clearly unsuitable patients as candidates for S-ICD implantation.
We aimed to clarify both the eligibility of patients with BrS for S-ICD implantation according to the surface ECG screening template at rest and the influence of exercise on ECG morphology in determining eligibility.
METHODS

Patients
All study protocols were approved by the Ethics Committee of Okayama University Hospital. All 112 patients with BrS who visited Okayama University Hospital from December 2015 to December 2016 were recruited. BrS was diagnosed based on the existence of type 1 ECG spontaneously or during drug challenge testing. 12 After excluding 2 patients (paced QRS complex, n = 1; inability to stand, n = 1), 110 patients were included in this study. Of these, 13 patients experienced ventricular fibrillation (VF) or aborted cardiac arrest and 39 patients experienced syncope. We assessed the clinical characteristics of participants, including age, sex, body mass index (BMI) and family history of sudden death before 45 years old. Genetic analysis for mutation of SCN5A was performed in 51 patients, and complied with the guidelines for human genome studies from the Ethics Committee of Okayama University. 
Standard 12-lead ECG
S-ICD screening ECG at rest
All subjects were assessed using supine and standing ECG limb lead recordings to simulate the three S-ICD sensing vectors, as reported previously. 13 ECG lead positions are shown in Figure. 1.
All patients were screened in three increments (5, 10, and 20 mm/mV) with a paper speed of 25 mm/s for a period of 10 seconds.
Candidacy was determined using the screening template of Boston Scientific (Natick, MA, USA). Patients were considered eligible for S-ICD when at least one sensing vector was present in any of the same leads in the supine and standing positions in all QRS-T complexes of the 10-second ECG strip at any three gains. All ECG readings were analyzed by two independent, blinded observers.
S-ICD screening ECG during exercise stress test
Forty-five consecutive patients who met the indication for S-ICD at rest and consented to further testing underwent a symptom-limited treadmill exercise test (TMT) using the Bruce protocol. Patients who declined to undergo the TMT or were unable to run on a treadmill machine were excluded. Limb lead recordings simulated the three S-ICD sensing vectors and the precordial lead was in the ordinary position. The symptom-limited Bruce protocol starts with a warm-up stage at low workload, followed by successive 2-minute stages with stepwise increments in workload. Tests were completed with a 5-minute recovery phase after reaching peak exercise. ECGs were acquired every 1 minute during and after exercise testing up to 5 minute into the recovery period. S-ICD eligibility was determined using the Boston Scientific screening template, at the following time points: (1) supine rest; (2) on standing; (3) at peak exercise; (4) at 1-minute recovery; (5) at 3-minute recovery; and (6) at 5-minute recovery. Peak voltages of QRS and T wave, the ratio of peak voltages of QRS to T wave, QRS duration, and corrected QT interval (QTc) were measured at each point. QTc was calculated using the Buzzet formula. Table 1 shows the baseline clinical characteristics of study participants.
Statistical analysis
RESULTS
Baseline characteristics of patients and S-ICD eligibility at rest
No significant differences in baseline clinical characteristics were seen between eligibility and ineligibility for S-ICD screening ECG.
Predictors of failure on standard 12-lead ECG
The results of uni-and multivariate analyses for comparison of factors associated with S-ICD screening ineligibility are shown in Table 2 were ineligible (n = 21) for S-ICD showed significantly greater frequencies of CRBBB and wide QRS interval in the standard 12-lead ECG.
Multivariate regression analysis identified CRBBB as an independent predictor of ineligibility for S-ICD according to screening ECG (Table 2 ).
Change in eligibility for S-ICD during exercise stress test
Of the 45 patients who were eligible for S-ICD according to screening at rest and underwent exercise testing, 11 patients became ineligible from S-ICD screening template during TMT. ECGs at peak exercise and during the recovery phase excluded these patients from eligibility for S-ICD (Fig. 2) . To clarify what kind of changes in morphology led to ineligibility during TMT, we assessed the point at which the 11 patients became ineligible. For this purpose, we chose the 3-minute recovery time point to assess for eligibility during TMT, because 9 of the 11 ineligible patients were found to be ineligible at this time point. Patients who became ineligible during TMT showed significantly higher voltage of T wave and lower ratio of voltages of QRS to T wave at the time of ineligibility compared to patients who remained eligible during TMT (Table 3 ). Figure 3 shows a representative example of a patient who became ineligible for S-ICD during exercise testing.
DISCUSSION
Main findings
S-ICD has been widely applied to patients, but evidence has been lacking regarding the eligibility of patients with BrS for S-ICD. The present findings represent early data from S-ICD screening in patients with BrS, and, to the best of our knowledge, the cohort of BrS patients in this investigation is the largest yet reported on. Eighty-one percent of BrS patients were eligible according to the screening template at rest, but 24% of patients who passed the screening at rest became ineligible during exercise testing. CRBBB was the only independent predictor of ineligibility for S-ICD on standard 12-lead ECG. 14 CRBBB = complete right bundle branch block; OR = odds ratio; 95%CI = 95% confidence interval.
Eligibility for S-ICD in BrS patients
F I G U R E 2
Change in eligibility for S-ICD during exercise stress test. Of the 45 patients who were eligible for S-ICD according to screening at rest and underwent exercise testing, 11 patients became ineligible from the S-ICD screening template during the treadmill test. These 11 patients became ineligible during peak to 3-minute recovery, and all appeared eligible again at 5-minute recovery Ratio of QRS/T-wave voltage 5.7 ± 2.9 6.7 ± 2.7 2.7 ± 0. 
TA B L E 3 Patient characteristics of S-ICD screening ECG during TMT
All patients
Prediction of factors for ineligibility for S-ICD on standard 12-lead ECG
Similar to conventional transvenous ICD, efforts should be made to ensure avoidance of inappropriate cardiac shocks from an S-ICD. Olde
Nordcamp et al. reported that the most common cause of inappropriate shock from an S-ICD was cardiac signal oversensing (73%), such as T-wave oversensing. 10 Previous reports have shown that patients with a negative T wave, 18, 19 extension of the QRS duration, 20 or QT interval prolongation 19 on standard 12-lead ECG have tended to fail the criteria of the screening template. In our study, multivariate analysis showed that only CRBBB was a significant predictor of ineligibility for S-ICD. To avoid inappropriate cardioversion of S-ICD, morphological changes on standard 12-lead ECG can provide initial clues to physicians to reconsider whether patients will be eligible for S-ICD. In particular, intermittent CRBBB is sometimes observed in BrS, and could be associated with inappropriate therapy using S-ICD. 21 
Limitations
Several limitations need to be considered for this study. First, only a single center was included, and not all patients who passed the S-ICD indication at rest could be included in exercise stress testing. Multicenter studies including larger numbers of patients thus need to be con- should be considered before S-ICD implantation for patients with BrS.
CONCLUSIONS
In this study, 19% of BrS patients for S-ICD were considered unsuitable for S-ICD when evaluated with a surface ECG screening template at rest. In addition, almost a quarter of patients who initially appeared eligible under resting screening ECG became ineligible during TMT. Exercise stress testing should be considered for patients with BrS before S-ICD implantation. On standard 12-lead ECG, CRBBB represented an independent predictor of failure to meet the indications for S-ICD.
During follow-up after S-ICD implantation, morphological changes in QRS on standard 12-lead ECG may alert physicians to patient ineligibility for implantation of this device.
